Literature DB >> 16728291

Development and evaluation of DASH diet tailored messages for hypertension treatment.

Margaret Scisney-Matlock1, Lynn Glazewki, Carolyn McClerking, Lauren Kachorek.   

Abstract

For this study, the Manage Associated Perceptions (MAP) of Dietary Behavior Study, researchers developed, evaluated, and tested messages tailored to improve compliance with the Dietary Approaches to Stop Hypertension (DASH) diet by gradually instilling healthy Cognitive Representations of the DASH Diet (CRDDs). The sample consisted of women from diverse backgrounds (N = 53), randomly assigned to two experimental groups (n = 13 and n = 14) and to two control groups (n = 12 and n = 14). The experimental groups performed a version of the intervention for 30 days. Data about dietary compliance and CRDDs were collected at 30, 60, and 90 days. Compared to control group members, experimental group members demonstrated greater improvements in CRDD scores and were significantly more compliant with the diet. Another significant finding was that older women were more compliant.

Entities:  

Mesh:

Year:  2006        PMID: 16728291     DOI: 10.1016/j.apnr.2005.05.005

Source DB:  PubMed          Journal:  Appl Nurs Res        ISSN: 0897-1897            Impact factor:   2.257


  9 in total

1.  Electronic feedback messages for home spirometry lung transplant recipients.

Authors:  Sarah J Pangarakis; Kathleen Harrington; Ruth Lindquist; Cynthia Peden-McAlpine; Stanley Finkelstein
Journal:  Heart Lung       Date:  2008 Jul-Aug       Impact factor: 2.210

2.  A Randomized Clinical Trial of a Tailored Lifestyle Intervention for Obese, Sedentary, Primary Care Patients.

Authors:  Charles B Eaton; Sheri J Hartman; Elizabeth Perzanowski; Guohui Pan; Mary B Roberts; Patricia M Risica; Kim M Gans; John M Jakicic; Bess H Marcus
Journal:  Ann Fam Med       Date:  2016-07       Impact factor: 5.166

3.  Sodium restriction in heart failure: benefit or harm?

Authors:  Matthew C Konerman; Scott L Hummel
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-02

4.  The effect of medical nutrition therapy on changes in dietary knowledge and DASH diet adherence in older adults with cardiovascular disease.

Authors:  E Racine; J L Troyer; J Warren-Findlow; W J McAuley
Journal:  J Nutr Health Aging       Date:  2011-12       Impact factor: 4.075

Review 5.  Interventions to enhance adherence to dietary advice for preventing and managing chronic diseases in adults.

Authors:  Sophie Desroches; Annie Lapointe; Stéphane Ratté; Karine Gravel; France Légaré; Stéphane Turcotte
Journal:  Cochrane Database Syst Rev       Date:  2013-02-28

6.  Tailored weight loss intervention in obese adults within primary care practice: rationale, design, and methods of Choose to Lose.

Authors:  Sheri J Hartman; Patricia M Risica; Kim M Gans; Bess H Marcus; Charles B Eaton
Journal:  Contemp Clin Trials       Date:  2014-06-15       Impact factor: 2.226

Review 7.  Strategies for implementing and sustaining therapeutic lifestyle changes as part of hypertension management in African Americans.

Authors:  Margaret Scisney-Matlock; Hayden B Bosworth; Joyce Newman Giger; Ora L Strickland; R Van Harrison; Dorothy Coverson; Nirav R Shah; Cheryl R Dennison; Jacqueline M Dunbar-Jacob; Loretta Jones; Gbenga Ogedegbe; Marian L Batts-Turner; Kenneth A Jamerson
Journal:  Postgrad Med       Date:  2009-05       Impact factor: 3.840

8.  Mail education is as effective as in-class education in hypertensive Korean patients.

Authors:  Miyong T Kim; Eun-Young Kim; Hae-Ra Han; Seonghee Jeong; Jong Eun Lee; Hyun Jeong Park; Kim B Kim; Martha N Hill
Journal:  J Clin Hypertens (Greenwich)       Date:  2008-03       Impact factor: 3.738

9.  Translating the Dietary Approaches to Stop Hypertension (DASH) diet for use in underresourced, urban African American communities, 2010.

Authors:  Melicia C Whitt-Glover; Jaimie C Hunter; Capri G Foy; Sara A Quandt; Mara Z Vitolins; Iris Leng; Lyndsey M Hornbuckle; Kara A Sanya; Alain G Bertoni
Journal:  Prev Chronic Dis       Date:  2013       Impact factor: 2.830

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.